Calyxt Inc - SIC # 5499 - MISCELLANEOUS FOOD STORES

Ticker Exchange SIC # Website Latest Ticker
CLXT Nasdaq 5499 https://calyxt.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Calyxt Inc

Calyxt Announces Stockholder Approval of Merger With Cibus - May 19th, 2023 8:01 pm
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update - May 1st, 2023 8:01 pm
Calyxt Completes One-for-Ten Reverse Stock Split - Apr 24th, 2023 8:35 pm
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC - Apr 18th, 2023 8:05 pm
Calyxt Announces Effective Date of Reverse Stock Split - Apr 7th, 2023 8:05 pm
Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update - Mar 6th, 2023 9:30 pm
Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update - Mar 2nd, 2023 9:01 pm
Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC - Feb 15th, 2023 12:30 pm
Plant-based biotech company Calyxt to merge with California firm - Jan 17th, 2023 8:37 pm
Calyxt Shares Surge On Merger Agreement Creating Agriculture-Focused Precision Gene Editing Company - Jan 17th, 2023 1:32 pm
Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement - Jan 17th, 2023 12:10 pm
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company - Jan 17th, 2023 11:30 am
Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil - Nov 18th, 2022 4:00 pm
Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule - Nov 17th, 2022 9:01 pm
Calyxt Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag - Nov 9th, 2022 12:05 pm
Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates - Nov 3rd, 2022 9:45 pm
Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update - Nov 3rd, 2022 8:01 pm
Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing - Nov 1st, 2022 11:00 am
Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time - Oct 27th, 2022 11:00 am
Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants - Oct 25th, 2022 11:00 am